A multicenter, open labelled, uncontrolled, phase IV clinical study to evaluate the health-related quality of life and sexual well-being in young (18-35) healthy Mirena [levonorgestrel intra uterine device] users switching from, oral contraceptives over the first year post-insertion.
Phase of Trial: Phase IV
Latest Information Update: 03 Feb 2011
At a glance
- Drugs Levonorgestrel (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Sponsors Bayer
- 30 Sep 2008 Actual end date (Oct 2007) added as reported by ClinicalTrials.gov.
- 30 Sep 2008 Additional trial identifier (91458) added as reported by ClinicalTrials.gov.
- 30 Sep 2008 Actual patient number (141) as reported by ClinicalTrials.gov.